非肌层浸润膀胱癌的一线膀胱内化疗：嵌合体还是“最高境界”？
First-line Intravesical Chemotherapy for Non-muscle-invasive Bladder Cancer: Chimera or "Ne Plus Ultra"?
发表日期：2023 Mar 18
作者：
Louis Lenfant, Ugo Pinar, Morgan Rouprêt, Thomas Seisen
来源：
EUROPEAN UROLOGY
摘要：
一线膀胱内化疗在非肌层侵犯性膀胱癌的新辅助治疗和术中化疗中已经得到测试。然而，可用数据高度异质性，需要进一步进行高质量研究，才能在这两个情况下开始使用。
版权所有©2023欧洲泌尿外科协会。由Elsevier B.V.出版。保留所有权利。
The efficacy of first-line intravesical chemotherapy for non-muscle-invasive bladder cancer has been tested in the neoadjuvant and chemoresection settings. However, the data available are highly heterogeneous and further high-quality studies are needed before its use can be embraced in either setting.Copyright © 2023 European Association of Urology. Published by Elsevier B.V. All rights reserved.